Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

COVID-19

As the risk of COVID-19 exposure stretches on, we have updated our official statement concerning working conditions for people with CLL / SLL (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) that you can download for your own reference and to share with the appropriate people in your life including HR and co-workers.
In light of the FDA’s announcements regarding the discontinuation of Emergency Use Authorization for both Evusheld  and Bebtelovimab, CLL Society and eight other patient advocacy organizations sent a letter to federal officials requesting them to immediately undertake thirteen specific actions that would help protect the estimated seven million Americans